Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edap Tms Sa ADR
(NQ:
EDAP
)
2.450
-0.070 (-2.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edap Tms Sa ADR
< Previous
1
2
3
4
Next >
EDAP Reports Third Quarter 2024 Financial Results
November 07, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
A Glimpse of Edap TMS's Earnings Potential
November 06, 2024
Via
Benzinga
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
November 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
October 01, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Earnings Outlook For Edap TMS
March 26, 2024
Via
Benzinga
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
September 19, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 29, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Reports Second Quarter 2024 Financial Results
August 28, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
August 07, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
August 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
July 19, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints Fran Schulz to Board of Directors
July 08, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
June 03, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Jefferies Global Healthcare Conference
May 22, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q1 2024
May 16, 2024
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
EDAP Reports First Quarter 2024 Financial Results
May 16, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
May 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
May 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
April 23, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
March 27, 2024
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
March 27, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
March 13, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
March 04, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
February 29, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
February 01, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
January 08, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
January 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.